Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Cyclic citrullinated peptide (CCP), antibody

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86200 refers to the laboratory test for measuring cyclic citrullinated peptide (CCP) antibody levels in the blood. This test is significant as it serves as a serum marker for rheumatoid arthritis, which is a chronic inflammatory condition primarily affecting the synovial membrane of joints. The presence of CCP antibodies can be an early indicator of rheumatoid arthritis, often detectable before the onset of clinical symptoms associated with the disease. The test is typically ordered alongside the rheumatoid factor test, identified by CPT® Code 86431, to provide a more comprehensive assessment of the patient's condition. To perform this test, a blood sample is collected through a procedure known as venipuncture, which is separately reportable. The serum obtained from the blood sample is then analyzed using a semiquantitative enzyme-linked immunosorbent assay (ELISA), a method that allows for the measurement of the concentration of CCP antibodies in the serum.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The test for cyclic citrullinated peptide (CCP) antibodies is indicated for the following conditions:

  • Rheumatoid Arthritis This test is primarily performed to aid in the diagnosis of rheumatoid arthritis, a chronic inflammatory disorder that affects the joints.
  • Early Detection The CCP antibody test may be utilized to identify the presence of rheumatoid arthritis before clinical symptoms manifest, allowing for earlier intervention.
  • Assessment of Disease Activity It can also be used to evaluate disease activity and monitor the progression of rheumatoid arthritis in patients already diagnosed.

2. Procedure

The procedure for conducting the cyclic citrullinated peptide (CCP) antibody test involves several key steps:

  • Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or supplements that could interfere with the test results. It is essential to ensure that the patient is adequately informed about the procedure and its purpose.
  • Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to draw blood. The site is cleaned with an antiseptic to minimize the risk of infection.
  • Step 3: Serum Separation Once the blood sample is collected, it is processed to separate the serum from the blood cells. This is typically done by centrifugation, which spins the sample at high speed to separate components based on density.
  • Step 4: Testing The serum is then subjected to a semiquantitative enzyme-linked immunosorbent assay (ELISA). This method involves adding specific reagents that react with the CCP antibodies present in the serum, allowing for the measurement of their concentration.
  • Step 5: Result Interpretation After the testing is complete, the results are analyzed and interpreted by a qualified laboratory professional. The findings are then reported to the physician, who will discuss the implications with the patient.

3. Post-Procedure

After the CCP antibody test is performed, there are generally no specific post-procedure care requirements for the patient. However, patients may be advised to drink plenty of fluids to help replenish any lost blood volume. It is also common for patients to experience minor discomfort or bruising at the venipuncture site, which typically resolves on its own. The physician will review the test results with the patient, discussing any necessary follow-up actions or additional testing that may be required based on the findings.

Short Descr CCP ANTIBODY
Medium Descr CYCLIC CITRULLINATED PEPTIDE ANTIBODY
Long Descr Cyclic citrullinated peptide (CCP), antibody
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Q4 Service for ordering/referring physician qualifies as a service exemption
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GW Service not related to the hospice patient's terminal condition
GA Waiver of liability statement issued as required by payer policy, individual case
GZ Item or service expected to be denied as not reasonable and necessary
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
PN Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
Date
Action
Notes
2006-01-01 Added First appearance in code book in 2006.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"